CGRPはCD4+ T細胞応答とアレルギー感作を抑制する
Xiaoshi Li1, Ying Zhang1, Wenlong Chen1
1Department of Biochemistry, SUSTech Homeostatic Medicine Institute, University Laboratory of Metabolism and Health of Guangdong, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Frontiers in immunology
|December 31, 2025
まとめ
カルシトニン遺伝子関連ペプチド(CGRP)と受容体活性化修飾タンパク質1(RAMP1)経路はCD4+ T細胞の活性化を抑制し、アレルギー感作を抑制する。CGRP治療はT細胞応答を調節することによりアレルギー性喘息を軽減する。
科学分野:
- 神経免疫学
- アレルギー学、免疫学
背景:
- カルシトニン遺伝子関連ペプチド(CGRP)は免疫調節に関与する神経ペプチドであるが、その適応免疫における役割はよく理解されていない。
- CGRP-RAMP1経路は、アレルギー感作中のCD4+ T細胞応答の重要な内在性調節因子として同定されている。
主な方法:
- マウスにおけるハウスダストマイト(HDM)を用いたアレルギー感作の誘発。
- CGRP+感覚神経線維の分布と免疫細胞上のRAMP1発現の分析。
- TCR-seq、パラバイオシス、養子移入、フローサイトメトリー、ATAC-seq、RNA-seqなどの技術を利用してCD4+ T細胞機能を研究した。
- CD4+ T細胞特異的RAMP1ノックアウトマウスとHDM誘発アレルギー性喘息モデルにおけるCGRP治療を用いた。
結論:
- CGRP-RAMP1経路は神経免疫軸として機能し、CD4+ T細胞の免疫生物学を直接調節することによりアレルギー感作を抑制する。
- CGRP治療は、この神経免疫経路を標的とすることにより、アレルギー性喘息の治療可能性を示す。
さらに関連する動画
関連する概念動画
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
GPCR Desensitization
7.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
Allergic Reactions
31.9K
Overview
31.9K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K


